发明授权
US08268971B2 Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
有权
用于调节肠道受体功能的抗体治疗和治疗糖尿病和肥胖症的方法
- 专利标题： Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
- 专利标题（中）： 用于调节肠道受体功能的抗体治疗和治疗糖尿病和肥胖症的方法
-
申请号： US12687660申请日： 2010-01-14
-
公开(公告)号： US08268971B2公开(公告)日： 2012-09-18
- 发明人: Barbara S. Fox
- 申请人： Barbara S. Fox
- 申请人地址： US MA Lexington
- 专利权人： Avaxia Biologics, Inc.
- 当前专利权人： Avaxia Biologics, Inc.
- 当前专利权人地址： US MA Lexington
- 代理机构： Elmore Patent Law Group, P.C.
- 代理商 Darlene A. Vanstone, Esq.; Carolyn S. Elmore, Esq.
- 主分类号： C12P21/08
- IPC分类号： C12P21/08 ; A61K39/395 ; C07K16/00
摘要：
The present invention provides pharmaceutical compositions formulated for direct delivery to the GI tract of a patient comprising an antibody specific for a target apical intestinal receptor. The present invention further provides methods of treating diseases and conditions in a patient comprising administering directly to the GI tract of the patient, compositions of the present invention wherein modulation of the target apical intestinal receptor by the antibody treats the condition.
公开/授权文献
信息查询
